Business Description
Concord Medical Services Holdings Ltd
NAICS : 622110
ISIN : US2062771058
Share Class Description:
FRA:C2CA: ADRDescription
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | -0.35 | |||||
| Debt-to-Equity | -1.55 | |||||
| Debt-to-EBITDA | -8.46 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -1.3 | |||||
| Beneish M-Score | -2.26 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 30.2 | |||||
| 3-Year EBITDA Growth Rate | 5.1 | |||||
| 3-Year EPS without NRI Growth Rate | 19.2 | |||||
| 3-Year FCF Growth Rate | 21.2 | |||||
| 3-Year Book Growth Rate | -43.1 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.99 | |||||
| 9-Day RSI | 42.51 | |||||
| 14-Day RSI | 45.68 | |||||
| 6-1 Month Momentum % | -44.55 | |||||
| 12-1 Month Momentum % | -54.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.32 | |||||
| Quick Ratio | 0.3 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 33.7 | |||||
| Days Sales Outstanding | 69.1 | |||||
| Days Payable | 81.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 21.36 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -14.26 | |||||
| Operating Margin % | -86.17 | |||||
| Net Margin % | -55.43 | |||||
| FCF Margin % | -73.62 | |||||
| ROA % | -4.89 | |||||
| ROIC % | -7.12 | |||||
| ROC (Joel Greenblatt) % | -10.43 | |||||
| ROCE % | -8.45 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.31 | |||||
| EV-to-EBIT | -18.68 | |||||
| EV-to-EBITDA | -18.68 | |||||
| EV-to-Revenue | 13.56 | |||||
| EV-to-FCF | -18.35 | |||||
| Price-to-Median-PS-Value | 0.12 | |||||
| Earnings Yield (Greenblatt) % | -5.35 | |||||
| FCF Yield % | -236.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Concord Medical Services Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 69.148 | ||
| EPS (TTM) (€) | -0.876 | ||
| Beta | 0.18 | ||
| Volatility % | 60.62 | ||
| 14-Day RSI | 45.68 | ||
| 14-Day ATR (€) | 0.045565 | ||
| 20-Day SMA (€) | 0.54075 | ||
| 12-1 Month Momentum % | -54.84 | ||
| 52-Week Range (€) | 0.326 - 1.41 | ||
| Shares Outstanding (Mil) | 43.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Concord Medical Services Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Concord Medical Services Holdings Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Concord Medical Services Holdings Ltd Frequently Asked Questions
What is Concord Medical Services Holdings Ltd(FRA:C2CA)'s stock price today?
The current price of FRA:C2CA is €0.48. The 52 week high of FRA:C2CA is €1.41 and 52 week low is €0.33.
When is next earnings date of Concord Medical Services Holdings Ltd(FRA:C2CA)?
The next earnings date of Concord Medical Services Holdings Ltd(FRA:C2CA) is .
Does Concord Medical Services Holdings Ltd(FRA:C2CA) pay dividends? If so, how much?
Concord Medical Services Holdings Ltd(FRA:C2CA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers